Abstract
-
Keywords
References
- 1. Lee KL., Ma JF, Shortlife LD. Neuroblastoma management, recurrence, and follow-up. Urol Clin N Am 2003: 30: 881-890.
- 2. Schilling FH, Spix C, Berthold F. Neuroblastoma screening at one year of age. N Engl J Med 2002; 346: 1047-5103.
- 3. Alexander F. Neuroblastoma. Urol Clin North Am 2002; 27: 393-402.
- 4. Castleberry RP. Biology and treatment of neuroblastoma. Pediatr Clin North Am 1997; 44: 919- 937.
- 5. Simpson JK, Gaze MN. Current management of neuroblastoma. Oncologist 1998; 3: 253-562.
- 6. Ritchey M. Pediatric urologic oncology. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology. 8th edition. Philadelphia: W.B. Saunders; 2002:2469-2475.
- 7. Woods WG, Gao R, Shuster JJ. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002; 346: 1041-1046.
- 8. Yamamoto K, Ohta S, Ito E. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol 2002; 20: 1209-1214.
- 9. Barrette S. Treatment complications in children diagnosed with neuroblastoma during a screening program. J Clin Oncol 2006; 24: 1542-1545.
- 10. Chamberlain J Screening for neuroblastoma: a review of the evidence. J Med Screen 1994; 1:169-175.
Abstract
Bu yazıda antenatal hidronefroz nedeniyle takip edilen ve pyeloplastiden sonra nöroblastom tanısı alan 8
aylık bir erkek çocuğun klinik özellikleri bildirilmiştir. Postnatal 3. ayda gerçekleştirilen sol pyeloplastinin
erken postoperatif döneminde belirgin hemoglobin, hematokrit düşüşü olması nedeniyle çekilen tomografide
tümör veya kolleksiyon lehine bulgu izlenmedi. Fakat postoperatif 4. aydaki kontrol ultrasonografisinde sol
sürrenalde kitle görüldü. Kan ve idrar testleri nöroblastom lehine sonuçlandı. Bunların üzerine yapılan
eksplorasyonda sol sürrenaldeki kitle eksize edildi ve iyi histopatolojik özelliklere sahip, evre 1 nöroblastom
tanısı konmuş oldu. Bu vakada olduğu gibi insidental olarak veya tarama programları ile tanısı konan düşük
riskli tümörler sadece cerrahi müdahale ile tedavi edilebilir
References
- 1. Lee KL., Ma JF, Shortlife LD. Neuroblastoma management, recurrence, and follow-up. Urol Clin N Am 2003: 30: 881-890.
- 2. Schilling FH, Spix C, Berthold F. Neuroblastoma screening at one year of age. N Engl J Med 2002; 346: 1047-5103.
- 3. Alexander F. Neuroblastoma. Urol Clin North Am 2002; 27: 393-402.
- 4. Castleberry RP. Biology and treatment of neuroblastoma. Pediatr Clin North Am 1997; 44: 919- 937.
- 5. Simpson JK, Gaze MN. Current management of neuroblastoma. Oncologist 1998; 3: 253-562.
- 6. Ritchey M. Pediatric urologic oncology. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology. 8th edition. Philadelphia: W.B. Saunders; 2002:2469-2475.
- 7. Woods WG, Gao R, Shuster JJ. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002; 346: 1041-1046.
- 8. Yamamoto K, Ohta S, Ito E. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol 2002; 20: 1209-1214.
- 9. Barrette S. Treatment complications in children diagnosed with neuroblastoma during a screening program. J Clin Oncol 2006; 24: 1542-1545.
- 10. Chamberlain J Screening for neuroblastoma: a review of the evidence. J Med Screen 1994; 1:169-175.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Case Reports |
| Authors | |
| Publication Date | May 11, 2015 |
| Published in Issue | Year 2009 Volume: 22 Issue: 1 |